MiMedx Group
MDXG
232 hedge funds and large institutions have $924M invested in MiMedx Group in 2017 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 97 increasing their positions, 52 reducing their positions, and 22 closing their positions.
118% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 22
87% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 52
11% more funds holding
Funds holding: 209 → 232 (+23)
9% less capital invested
Capital invested by funds: $1.02B → $924M (-$94M)
59% less call options, than puts
Call options by funds: $18.6M | Put options by funds: $45.6M
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.2M |
| 2 |
Millennium Management
New York
|
+$21.8M |
| 3 |
BlackRock
New York
|
+$18.9M |
| 4 |
Morgan Stanley
New York
|
+$16.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tiedemann Advisors
New York
|
-$22.7M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$22.5M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$14.8M |
| 4 |
Two Sigma Investments
New York
|
-$11.5M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$7.91M |
MDXG Hedge Fund Activity: Q3 2017 in Review
232 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q3 2017, worth a combined $924M — down 9.2% from $1.02B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new MDXG positions and 22 closed out — a net gain of 26 holders — while 97 added to existing stakes and 52 trimmed.
The largest buyer was Vanguard Group, adding an estimated $28.2M. The largest seller was Tiedemann Advisors, cutting an estimated $22.7M.
- 232 institutional investors held MiMedx Group (MDXG) as of Q3 2017, up from 209 in Q2 2017.
- Funds reported $924M of MiMedx Group stock for Q3 2017, down 9.2% quarter-over-quarter.
- 48 funds opened new MiMedx Group positions in Q3 2017 and 22 closed out, a net change of +26 holders.
- The largest MiMedx Group buyer in Q3 2017 was Vanguard Group, an estimated $28.2M added.
- The largest MiMedx Group seller in Q3 2017 was Tiedemann Advisors, an estimated $22.7M sold.
Based on aggregated 13F filings for Q3 2017.